Testing for COVID-19 in lung cancer patients

por Passaro, A., Peters, S., Mok, T.S.K., Attili, I., Mitsudomi, T., de Marinis, F.
Publicado 2020

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association...

por Gridelli, C., Peters, S., Mok, T., Forde, P.M., Reck, M., Attili, I., de Marinis, F.
Publicado 2021

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Canc...

por Ardizzoni, A., Addamo, G. F., Baldini, E., Borghini, U., Portalone, L., De Marinis, F., Lionetto, R., Conte, P. F., Bruzzi, P., Pennucci, M. C.
Publicado 1995

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

por Cappuzzo, F, Novello, S, De Marinis, F, Franciosi, V, Maur, M, Ceribelli, A, Lorusso, V, Barbieri, F, Castaldini, L, Crucitta, E, Marini, L, Bartolini, S, Scagliotti, G V, Crinò, L
Publicado 2005

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

por Spitaleri, G., Trillo Aliaga, P., Catania, C., Signore, E. Del, Attili, I., Santoro, C., Giugliano, F., Berton Giachetti, P.P.M, Curigliano, G., Passaro, A., de Marinis, F.
Publicado 2023

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lun...

por Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
Publicado 2021

The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report

por Hardenberg, M.C., Patel, B., Matthews, C., Califano, R., Garcia Campelo, R., Grohe, C., Hong, M.H., Liu, G., Lu, S., de Marinis, F., Pérol, M., Soo, R.A., Stiles, B.M., Tiseo, M., Tsuboi, M.
Publicado 2022

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

por Schuler, M., Yang, J. C.-H., Park, K., Kim, J.-H., Bennouna, J., Chen, Y.-M., Chouaid, C., De Marinis, F., Feng, J.-F., Grossi, F., Kim, D.-W., Liu, X., Lu, S., Strausz, J., Vinnyk, Y., Wiewrodt, R., Zhou, C., Wang, B., Chand, V. K., Planchard, D.
Publicado 2016

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONIC...

por Baldini, E., Tibaldi, C., Ardizzoni, A., Salvati, F., Antilli, A., Portalone, L., Barbera, S., Romano, F., De Marinis, F., Migliorino, M. R., Noseda, M. A., Borghini, U., Crippa, M., Ferrara, G., Raimondi, M., Fioretti, M., Bandera, M., Pennucci, M. C., Galeasso, G., Cacciani, G. C., Lepidini, G., Sunseri, G., Lanfranco, C., Rinaldi, M., Rosso, R.
Publicado 1998